{"id":"https://openalex.org/W1973372425","doi":"https://doi.org/10.1254/jjp.68.345","title":"OPC-21268 Antagonizes Arginine Vasopressin-Induced Vasoconstrictor Response in the Spinally-Anesthetized Dog","display_name":"OPC-21268 Antagonizes Arginine Vasopressin-Induced Vasoconstrictor Response in the Spinally-Anesthetized Dog","alternate_titles":[],"publication_year":1995,"publication_date":"1995-07-01","ids":{"openalex":"https://openalex.org/W1973372425","doi":"https://doi.org/10.1254/jjp.68.345","mag":"1973372425","pmid":"https://pubmed.ncbi.nlm.nih.gov/7474558"},"language":"en","primary_location":{"id":"doi:10.1254/jjp.68.345","doi":"https://doi.org/10.1254/jjp.68.345","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.68.345","pdf_url":"https://www.sciencedirect.com/science/article/pii/S002151981935499X/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973372425"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S002151981935499X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014007528","display_name":"Tomihiko Chihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomihiko Chihara","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006757027","display_name":"Shigeki Nakamura","orcid":"https://orcid.org/0000-0001-5272-8886","observed_orcids":["https://orcid.org/0000-0001-5272-8886"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeki Nakamura","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077585050","display_name":"Toshiyuki Onogawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyuki Onogawa","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086023651","display_name":"Tatsuya Yamashita","orcid":"https://orcid.org/0000-0002-3602-8086","observed_orcids":["https://orcid.org/0000-0002-3602-8086"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuya Yamashita","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoshitaka Yamamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitaka Yamamura","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000962006","display_name":"Toyoki Mori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Toyoki Mori","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103466648","display_name":"Michiaki Tominaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michiaki Tominaga","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113922205","display_name":"Youichi Yabuuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Youichi Yabuuchi","raw_affiliation_strings":["2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Kagasuno 463-10, Kawauchi-cho, Tokushima 771-01, Japan","institution_ids":["https://openalex.org/I114030911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5000962006"],"corresponding_institution_ids":["https://openalex.org/I114030911"],"apc_list":null,"apc_paid":null,"fwci":0.5207,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.61928007,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"68","issue":"3","first_page":"345","last_page":"348"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.03150000050663948,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opc-21268","display_name":"OPC-21268","score":1.0},{"id":"https://openalex.org/keywords/vasopressin","display_name":"vasopressin","score":0.972000002861023},{"id":"https://openalex.org/keywords/v1-receptor-antagonist","display_name":"V1 receptor antagonist","score":0.8169999718666077},{"id":"https://openalex.org/keywords/vasoconstriction","display_name":"vasoconstriction","score":0.847000002861023},{"id":"https://openalex.org/keywords/dose-response-shift","display_name":"dose-response shift","score":0.7269999980926514},{"id":"https://openalex.org/keywords/vasopressin-receptor-antagonism","display_name":"vasopressin receptor antagonism","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2776370428","wikidata":"https://www.wikidata.org/wiki/Q21124841","display_name":"Vasopressin","level":2,"score":0.9497043490409851},{"id":"https://openalex.org/C90474776","wikidata":"https://www.wikidata.org/wiki/Q24784390","display_name":"Vasopressin receptor","level":4,"score":0.7343936562538147},{"id":"https://openalex.org/C2777468819","wikidata":"https://www.wikidata.org/wiki/Q173670","display_name":"Arginine","level":3,"score":0.7277584075927734},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6763046979904175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6510927677154541},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6400436758995056},{"id":"https://openalex.org/C2779881253","wikidata":"https://www.wikidata.org/wiki/Q1587028","display_name":"Vasopressin Antagonists","level":4,"score":0.5967156887054443},{"id":"https://openalex.org/C2779961880","wikidata":"https://www.wikidata.org/wiki/Q1067506","display_name":"Vasoconstriction","level":2,"score":0.48133453726768494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4304215908050537},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3621916174888611},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2730979919433594},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.08139872550964355},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.03239840269088745}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001127","descriptor_name":"Arginine Vasopressin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014661","descriptor_name":"Vasoconstriction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1254/jjp.68.345","doi":"https://doi.org/10.1254/jjp.68.345","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.68.345","pdf_url":"https://www.sciencedirect.com/science/article/pii/S002151981935499X/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:7474558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7474558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1254/jjp.68.345","doi":"https://doi.org/10.1254/jjp.68.345","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jjp.68.345","pdf_url":"https://www.sciencedirect.com/science/article/pii/S002151981935499X/pdf","source":{"id":"https://openalex.org/S190179609","display_name":"The Japanese Journal of Pharmacology","issn_l":"0021-5198","issn":["0021-5198","1347-3506"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W1973372425.pdf"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1969811372","https://openalex.org/W1971921835","https://openalex.org/W1994292735","https://openalex.org/W2009645981","https://openalex.org/W2020840952","https://openalex.org/W2029112076","https://openalex.org/W2068916360","https://openalex.org/W2072863532","https://openalex.org/W2090971571","https://openalex.org/W2261486314"],"related_works":["https://openalex.org/W1969811372","https://openalex.org/W3100838559","https://openalex.org/W2020840952","https://openalex.org/W2090971571","https://openalex.org/W2009645981","https://openalex.org/W2257656211","https://openalex.org/W2276333604","https://openalex.org/W375277753","https://openalex.org/W2412547722"],"abstract_inverted_index":{"We":[0],"studied":[1],"the":[2,10,17,36,55,60],"antagonistic":[3],"actions":[4],"of":[5,23,35,47],"OPC-21268":[6,20,48,66],"(1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3,4-dihydro-":[7],"2(1H)-quinolinone)":[8],"on":[9],"arginine":[11],"vasopressin":[12],"(AVP)-induced":[13],"vasoconstrictor":[14,57],"response":[15,58],"in":[16,41,59,72,76,81],"spinally-anesthetized":[18],"dog.":[19],"at":[21],"doses":[22,46],"0.3,":[24],"1.0":[25],"and":[26],"3.0":[27],"mg/kg,":[28],"i.v.":[29],"produced":[30],"a":[31,42,69],"rightward":[32],"parallel":[33],"shift":[34],"dose-response":[37],"curves":[38],"for":[39],"AVP":[40],"dose-dependent":[43],"manner.":[44],"The":[45],"were":[49],"similar":[50],"to":[51],"those":[52],"that":[53,65],"inhibited":[54],"AVP-induced":[56],"rat.":[61],"This":[62],"observation":[63],"suggests":[64],"acts":[67],"as":[68,78,80],"V1-AVP-receptor":[70],"antagonist":[71],"peripheral":[73],"resistance":[74],"vessels":[75],"dogs":[77],"well":[79],"rats.":[82]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973372425","counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
